Professor Jonathan Kimmelman, Director of the Biomedical Ethics Unit, participated in a Globe and Mail panel on stem cells.
Learn more and watch the recording.
U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been...
Experts working in the field of vaccine development tend to believe that an effective vaccine is not likely to be available for the general public before the fall of 2021. In a paper published...
Thousands of healthy volunteers, including hundreds of Canadians, have offered to try getting injected with a potential vaccine and then purposely becoming infected with COVID-19 to test if the...
Jonathan Kimmelman, director of biomedical ethics at McGill University, agreed companies have some obligation to continue to provide care for patients who take part in studies to test experimental...
RSS